共 50 条
Current aspects of pulmonary arterial hypertension and therapeutics
被引:1
作者:
Li, Xianchi
[1
]
Liu, Yuanyuang
[1
]
Zhang, Peiying
[1
]
机构:
[1] Xuzhou Cent Hosp, Xuzhou, Peoples R China
来源:
MINERVA CARDIOANGIOLOGICA
|
2017年
/
65卷
/
02期
关键词:
Hypertension;
pulmonary;
Therapeutics;
Adrenergic beta-antagonists;
RIGHT-VENTRICULAR FUNCTION;
CALCIUM-CHANNEL BLOCKERS;
LONG-TERM RESPONSE;
SIGNALING CONTRIBUTES;
AEROBIC EXERCISE;
SURVIVAL;
PROSTACYCLIN;
MANAGEMENT;
PHYSIOLOGY;
DISEASE;
D O I:
10.23736/S0026-4725.16.04266-3
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
The pulmonary arterial hypertension (PAH) patients have high rate of mortality due to right ventricle (or ventricular) (RV) failures. A lot of research work is being carried out in the area, however no treatment is available that could contrast the rise in mortality rates in PAH patients. beta 1-adrenoceptor blockers (beta-blockers, BB) reduced mortality in left heart failure, but they do not explored much at clinical level. Recent studies suggest beta-blockers might be beneficial in PAH; however the mechanisms remain unknown. The present review article would put light on all these aspects of PAH along with latest ways for the management of PAH.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 50 条